Montelukast helps to reduce inflammation and may be used to prevent asthma attacks in adults and children at least 2 years old. Montelukast pregnancy and
Pregnant Women: MINT-MONTELUKAST should be used during pregnancy only if clearly montelukast chewable tablets. (as montelukast sodium).
One chewable tablet contains montelukast sodium, which is equivalent to 5 mg montelukast. Singulair may be used during pregnancy only if it is considered to
Pregnancy - Montelukast has no acceptable risks when used during the period of pregnancy. Lactation - Using Montelukast during lactation
montelukast in pregnancy is likely to outweigh any theoretical risk posed to the fetus. Montelukast therapy should not be discontinued on
Advice and warnings for the use of Montelukast (Singulair) during pregnancy. FDA Pregnancy Category B - No proven risk in humans.
Most studies suggest that asthma severity prior to pregnancy is related to asthma severity during pregnancy Montelukast use during pregnancy:
Montelukast may be used during pregnancy only if it is considered to be clearly essential. Use during lactation. Studies in rats have shown that montelukast
Special Populations. Pregnant Women: Montelukast sodium has not been studied in pregnant women. MONTELUKAST should be used during pregnancy only
Comments